Brii Biosciences Ltd Business Update Call: HIV Ph 1 Study Status Transcript
Good day and thank you for standing by. Welcome to Brii Biosciences. This is Update Call HIV Phase 1 Study Status. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) And now, I like to hand the conference over to Ms. Chris Fang, Investor Relations Director all Brii Biosciences. Thank you, please go ahead.
Yes, thank you, operator. And good day, ladies and gentlemen who join the Brii Bio for HIV update call. So, for joining me today's call, we have our Dr. David Margolis, which is our Vice President, Head of Infectious Disease TA. And also we have our CFO and Joint Company Secretary, Dr. Ankang Li.
We noticed that recently, a lot of that are if not related trial. So we're going to welcome David to have a brief introduction. And then we open the Q&A session. Thank you. David, please go ahead.
Yes, thank you. And hi, everyone. I appreciate you joining.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
